CONTINUUS is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM). The company is a spin-out company from a multi-year collaboration between MIT and Novartis on Continuous Manufacturing. They specialize in end-to-end Integrated Continuous Manufacturing (ICM), which integrates both the upstream production of API and the downstream formulation steps into a single seamless continuous process.
Service Offerings:
API formation steps with final drug product formulation